Odiparcil For The Prevention Of Venous Thromboembolism

Completed · Phase 2

Conditions studied: Deep Vein Thrombosis, Fibrillation, Atrial, Venous Thromboembolism, Pulmonary Embolism

In brief

Odiparcil is being studied to determine if it can prevent blood clots from forming after a total knee replacement and also to prove that odiparcil is safe.

Key facts

Study ID

NCT00244725

Run by

GlaxoSmithKline

People needed

961

Starts

2005-09-01

Expected to finish

2006-09-01

Last updated by the study team

2017-05-02

Who can join

Age: 35 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Women must be unable to have children.
• Will have a total knee replacement.

You may not qualify if…

• Allergic to any X-ray dye.
• Allergies or reactions to warfarin or coumadin.
• Previous VTE (venous thromboembolism) or deep vein thrombosis (DVT).
• On anticoagulation therapy.
• Renal impairment.
• Participated in any clinical trial in the past 30 days.

Where it is running

• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Banning, California, United States
• GSK Investigational Site — Sacramento, California, United States
• GSK Investigational Site — Torrance, California, United States
• GSK Investigational Site — Yuba City, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Lonetree, Colorado, United States
• GSK Investigational Site — Clearwater, Florida, United States
• GSK Investigational Site — DeLand, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Sarasota, Florida, United States
• GSK Investigational Site — Sarsota, Florida, United States
• GSK Investigational Site — St. Petersburg, Florida, United States
• GSK Investigational Site — Decatur, Georgia, United States
• GSK Investigational Site — Boise, Idaho, United States
• GSK Investigational Site — Lexington, Kentucky, United States
• GSK Investigational Site — Baton Rouge, Louisiana, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Warren, Michigan, United States
• GSK Investigational Site — Mineola, New York, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.